Association of the glycemic background patterns and the diabetes management efficacy in poorly controlled type 2 diabetes

Table 8 Medication utilization after 12 months: Group A vs group B, n (%)

Medication	Usage	Group A	Group B	All patients	P value
MTF	Yes	40 (78.4)	64 (79)	104 (78.8)	0.937
	No	11 (21.6)	17 (21)	28 (21.2)
DPP-IV	Yes	27 (52.9)	63 (77.8)	90 (68.2)	0.003a
	No	24 (47.1)	18 (22.2)	42 (31.8)
SGLT2	Yes	37 (72.5)	64 (79)	101 (76.5)	0.394
	No	14 (27.5)	17 (21)	31 (23.5)
Pioglitazone	Yes	19 (37.3)	33 (40.7)	52 (39.4)	0.690
	No	32 (62.7)	48 (59.3)	80 (60.6)
Basal insulin	Yes	4 (7.8)	33 (40.7)	37 (28)	0.000a
	No	47 (92.2)	48 (59.3)	95 (72)
Basal-bolus insulin	Yes	4 (7.8)	15 (18.5)	19 (14.4)	0.089
	No	47 (92.2)	66 (81.5)	113 (85.6)
Mixed insulin	Yes	2 (3.9)	12 (14.8)	14 (10.6)	0.048a
	No	49 (96.1)	69 (85.2)	118 (89.4)

^aP < 0.05.

MTF: Metformin; DPP-IV: Dipeptidyl peptidase IV inhibitors; SGLT2: Sodium-glucose transport protein 2 inhibitors.